Neuropathology of Parkinson disease

Dickson, Dennis W.·2018·Parkinsonism & Related Disorders

Cited by (623)

Items 301–400 of 623

  1. The effects of chronic subthalamic stimulation on nonmotor symptoms in advanced Parkinson’s disease, revealed by an online questionnaire program
    Minako Kawaguchi, Kazuhiro Samura, Yasushi Miyagi, Tsuyoshi Okamoto, Ryo Yamasaki, Nobutaka Sakae, Fumiaki Yoshida, Koji Iihara · 2020 · Acta Neurochirurgica
  2. Inhibition of NK1R attenuates LPS-induced microglial inflammation and consequent death of PC12 cells
    Weifeng Jiang, Xiaoying Wang, Wei Wang, Fang Hua, Zunsheng Zhang, Zuohui Zhang, Jie Xiang, Xinxin Yang · 2020 · Brain Research Bulletin
  3. A simple-to-use web-based calculator for survival prediction in Parkinson’s disease
    Yunliang Tang, Jiao Wang, Gengfa Chen, Wen Ye, Nao Yan, Zhen Feng · 2021 · Aging
  4. Cost-effectiveness of opicapone and entacapone in reducing OFF-time in Parkinson’s disease patients treated with levodopa/carbidopa
    Ryan N. Hansen, Kangho Suh, Michael Serbin, Chuck Yonan, Sean D. Sullivan · 2021 · Journal of Medical Economics
  5. Brain organoids as precision models for neurodegenerative diseases: from disease modeling to drug discovery
    Yanxu Zheng, Wenke Zhou, Haozhe Chang, Kuihong Zheng · 2026 · Frontiers in Neuroscience
  6. (HIIT-The Track) High-Intensity Interval Training for People with Parkinson’s Disease: Individual Response Patterns of (Non-)Motor Symptoms and Blood-Based Biomarkers—A Crossover Single-Case Experimental Design
    Elvira S Amaral Gomes, Odile A. van den Heuvel, Marc B. Rietberg, Vincent de Groot, Mark A. Hirsch, Wilma D. J. van de Berg, Richard T. Jaspers, Chris Vriend, Tim Vanbellingen, Erwin E. H. van Wegen · 2023 · Brain Sciences
  7. LRRK2 Kinase Inhibitor PF-06447475 Protects Drosophila melanogaster against Paraquat-Induced Locomotor Impairment, Life Span Reduction, and Oxidative Stress
    Diana Alejandra Quintero-Espinosa, Marlene Jiménez-Del-Río, Carlos Velez‐Pardo · 2024 · Neurochemical Research
  8. The Link Between Paraquat and Demyelination: A Review of Current Evidence
    Renata Silva, Ana Filipa Sobral, Ricardo Jorge Dinis‐Oliveira, Daniel José Barbosa · 2024 · Antioxidants
  9. Virtual Reality Game with Haptic Feedback for Upper Limb Rehabilitation in Parkinson’s Disease
    Meldin Bektic, Brittany E. Smith, Angela L. Ridgel, Kwangtaek Kim · 2024 · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC)
  10. Application of α-Syn Real-Time Quaking-Induced Conversion for Brain and Skin Specimens of the Chinese Patients With Parkinson’s Disease
    Dongdong Chen, Ling Jiao, Yue Ming Huang, Kang Xiao, Liping Gao, Cao Chen, Qi Shi, Xiao‐Ping Dong · 2022 · Frontiers in Aging Neuroscience
  11. Discontinuous Galerkin approximations of the heterodimer model for protein–protein interaction
    Paola Francesca Antonietti, Francesca Bonizzoni, Mattia Corti, Agnese Dall’Olio · 2024 · Computer Methods in Applied Mechanics and Engineering
  12. The Neuropathologic Substrates of Vascular-Ischemic Dementia
    K. A. Jellinger · 2005 · Humana Press eBooks
  13. Pharmacogenetic profile and the development of the dyskinesia induced by levodopa-therapy in Parkinson’s disease patients: a population-based cohort study
    Erinaldo Ubirajara Damasceno dos Santos, Isaura Isabelle Fonseca Gomes da Silva, Amdore Guescel Asano, Nadja Maria Jorge Asano, Maria de Mascena Diniz Maia, Paulo Roberto Eleutério de Souza · 2020 · Molecular Biology Reports
  14. Three-Dimensional Analysis of Sex- and Gonadal Status- Dependent Microglial Activation in a Mouse Model of Parkinson’s Disease
    Amandine Isenbrandt, Katherine Coulombe, Marc Morissette, Mélanie Bourque, Jérôme Lamontagne‐Proulx, Thérèse Di Paolo, Denis Soulet · 2023 · Pharmaceuticals
  15. A systematic review of the challenges, emerging solutions and applications, and future directions of PET/MRI in Parkinson’s disease
    Isabella Hoi Kei Leung, Mark W. Strudwick · 2024 · EJNMMI Reports
  16. Targeting the Sirtuin–1/PPAR–Gamma Axis, RAGE/HMGB1/NF-κB Signaling, and the Mitochondrial Functions by Canagliflozin Augments the Protective Effects of Levodopa/Carbidopa in Rotenone-Induced Parkinson’s Disease
    Mennatallah A. Elkady, Ahmed M. Kabel, Lamees Mohamed Dawood, Azza I. Helal, Hany M. Borg, Hanan Abdelmawgoud Atia, Nesreen Mohammed Sabry, Nouran Magdy Moustafa, El‐Shaimaa A. Arafa, Shuruq E. Alsufyani et al. · 2024 · Medicina
  17. Neuromorphic chips for biomedical engineering
    Kaiyang Wang, Shuhui Ren, Yunfang Jia, Xiaobing Yan, Lizhen Wang, Yubo Fan · 2025 · Mechanobiology in Medicine
  18. Cholinergic basal forebrain degeneration in isolated REM sleep behaviour disorder
    Ryul Kim, Bora Jin, Heejung Kim, Kyung Ah Woo, Eun Jin Yoon, Seo-Yeon Kim, Jung Hwan Shin, Hyun Woo Nam, Yoon‐Keun Kim, Beomseok Jeon et al. · 2025 · Brain
  19. The Anti-Inflammatory Actions of Soluble Klotho in Brain Aging and Its Main Associated Diseases
    Héctor Eduardo López-Valdés, Martín Hernández-Lucas, Gustavo D. J. Rodríguez-Fabián, Nadia F. Esteban-Román, Roger Gutiérrez-Juárez, Isabel Arrieta‐Cruz, Hilda Martínez‐Coria · 2025 · International Journal of Molecular Sciences
  20. Thermoregulatory Dysfunction in Parkinson’s Disease: Mechanisms, Implications, and Therapeutic Perspectives
    Zechariah S. Pressnell, Lee E. Neilson, Domenico Tupone, Ronald F. Pfeiffer, Delaram Safarpour · 2025 · Cells
  21. Clinical, Biological, and Functional Connectivity Profile of Patients With De Novo Parkinson Disease Who Are APOE ε4 Carriers
    Matteo Conti, Davide Mascioli, Clara Simonetta, Valerio Ferrari, Jacopo Bissacco, Silvio Bagetta, Federico Carparelli, Sergio Bernardini, Francesca Di Giuliano, Enrica Marchionni et al. · 2025 · Neurology
  22. Dipeptide mimetic of BDNF ameliorates motor dysfunction and striatal apoptosis in 6-OHDA-induced Parkinson’s rat model: Considering Akt and MAPKs signaling
    Bita Firouzan, Farideh Iravanpour, Fatemeh Abbaszadeh, Valery Kh. Akparov, Jalal Zaringhalam, Rasoul Ghasemi, Nader Maghsoudi · 2023 · Behavioural Brain Research
  23. Single-nucleus transcriptomics reveals disease- and pathology-specific signatures in α-synucleinopathies
    Gonzalo S. Nido, Martina Castelli, Sepideh Mostafavi, Anna Rubiolo, Omnia Shadad, Guido Werner Alves, Ole‐Bjørn Tysnes, Irene H Flønes, Christian Dölle, Charalampos Tzoulis · 2024 · Brain
  24. An innovative method for the detection of alpha synuclein, a potential biomarker of Parkinson's disease: quartz tuning fork-based mass sensitive immunosensor design
    Münteha Nur Sonuç Karaboğa, Mehmet Altay Ünal, Fikret Arı, Mustafa Kemal Sezgintürk, Síbel A. Özkan · 2024 · Physical Chemistry Chemical Physics
  25. Parkinson’s disease speech production network as determined by graph-theoretical network analysis
    Jana Schill, Kristina Simonyan, Simon Lang, Christian Mathys, Christiane M. Thiel, Karsten Witt · 2023 · Network Neuroscience
  26. α-Synuclein Degradation in Brain Pericytes Is Mediated via Akt, ERK, and p38 MAPK Signaling Pathways
    Miki Yokoya, Fuyuko Takata, Takuro Iwao, Junichi Matsumoto, Yasuyoshi Tanaka, Hisataka Aridome, Miho Yasunaga, Junko Mizoguchi, Kazunori Sano, Shinya Dohgu · 2025 · International Journal of Molecular Sciences
  27. Are we ready for a biological diagnosis of Parkinson’s Disease?
    Angelo Tiziano Cimmino, Giulia Di Lazzaro, Antonio Pisani, Anna Rita Bentivoglio, Paolo Calabresi · 2025 · Cell Death and Disease
  28. Duzhong Fang Attenuates the POMC-Derived Neuroinflammation in Parkinsonian Mice
    Lili Li, Shanshan Fan, Wenqi Zhang, Dongna Li, Zhen Yu Yang, Pengwei Zhuang, Juan Han, Hong Guo, Yanjun Zhang · 2021 · Journal of Inflammation Research
  29. Prediagnostic expressions in health records predict mortality in Parkinson's disease: A proof-of-concept study
    Tomi Kuusimäki, Jani Sainio, Samu H. Kurki, Tero J. Vahlberg, Valtteri Kaasinen · 2022 · Parkinsonism & Related Disorders
  30. The substantia nigra modulates proximal colon tone and motility in a vagally‐dependent manner in the rat
    Tiaosi Xing, Giorgia Nanni, Cameron R. Burkholder, Kirsteen N. Browning, Renato Alberto Travagli · 2023 · The Journal of Physiology
  31. Haptic-Enhanced Mixed Reality for Upper Limb Rehabilitation in Parkinson’s Disease
    Nafees Mahmood, Anna E. Anello, Jin Woo Kim, Kwangtaek Kim, Brittany E. Smith, Angela L. Ridgel · 2024 · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC)
  32. Impulse control in Parkinson’s disease: Distinct effects between action and choice
    Aliya C. M. Warden, Craig J. McAllister, Marit F. L. Ruitenberg, Hayley J. MacDonald · 2025 · Neuroscience & Biobehavioral Reviews
  33. Mapping the Interactive Effects of ApoE Gene Polymorphism on Caudate Functional Connectivity in Mild Cognitive Impairment Associated With Parkinson’s Disease
    Song’an Shang, Yu‐Chen Chen, Hongying Zhang, Weiqiang Dou, Long Qian, Xindao Yin, Jingtao Wu · 2020 · Frontiers in Neuroscience
  34. The role of type 2 Diabetes mellitus as a risk factor for Alzheimer's and Parkinson's diseases
    Kellen Mariane Athaide Rocha, Aline da Silva Goulart, Márcio Tavares Costa, Andréia Caroline Fernandes Salgueiro, Vanderlei Folmer · 2021 · Research Society and Development
  35. Acute Cardiovascular Responses to Self-selected Intensity Exercise in Parkinson's Disease
    Hélcio Kanegusuku, Gabriel Grizzo Cucato, Paulo Longano, Erika Okamoto, Maria Elisa Pimentel Piemonte, Marília de Almeida Correia, Raphael Mendes Ritti‐Dias · 2021 · International Journal of Sports Medicine
  36. Noninvasive neuromodulation in Parkinson's disease: Neuroplasticity implication and therapeutic perspectives
    Giuseppe Cosentino, Massimiliano Todisco, Fabio Blandini · 2022 · Handbook of clinical neurology
  37. Olfactory dysfunction and striatal dopamine transporter binding in motor subtypes of Parkinson’s disease
    Fardin Nabizadeh, Fatemeh Sodeifian, Kasra Pirahesh · 2022 · Neurological Sciences
  38. Association Between Rheumatoid Arthritis and Risk of Parkinson's Disease: A Meta-Analysis and Systematic Review
    Dongxiu Li, Xia Hong, Tingyu Chen · 2022 · Frontiers in Neurology
  39. Role of Astrogliosis in the Pathogenesis of Parkinson’s Disease: Insights into Astrocytic Nrf2 Pathway as a Potential Therapeutic Target
    Bharat Bhushan, Niraj Kumar Singh · 2023 · CNS & Neurological Disorders - Drug Targets
  40. Fine-Tuned Machine Learning Classifiers for Diagnosing Parkinson’s Disease Using Vocal Characteristics: A Comparative Analysis
    Mehmet Meral, Ferdi Özbilgin, Fatih Durmuş · 2025 · Diagnostics
  41. Polydopamine nanoparticles as immunomodulators: inhibition of M1 microglial polarization
    Maria Cristina Ceccarelli, Luigi Lai, Alessio Carmignani, Matteo Battaglini, Gianni Ciofani · 2025 · Frontiers in Bioengineering and Biotechnology
  42. Deep learning enhanced ALPS reveals genetic and environmental factors of brain glymphatic function
    Cha Lin, Hao Wu, Wenbiao Xian, Yifan Zheng, Wenxuan Du, Xinyi Chen, Jinxia Li, Weineng Chen, Lishan Lin, Fengjuan Su et al. · 2026 · EBioMedicine
  43. Reduced syntactic recursion in spontaneous speech of Parkinson's disease patients
    Julia Henkel, Christian Johannes Hartmann, Valentina Niccolai, Ruben van de Vijver, Alfons Schnitzler, Katja Biermann‐Ruben · 2023 · Acta Psychologica
  44. Disease-Modifying Effects of Vincamine Supplementation in Drosophila and Human Cell Models of Parkinson’s Disease Based on DJ-1 Deficiency
    F. Sanz, Cristina Solana‐Manrique, Nuria Paricio · 2023 · ACS Chemical Neuroscience
  45. Does transcranial direct current stimulation of the primary motor cortex improve implicit motor sequence learning in Parkinson's disease?
    Mahyar Firouzi, Kris Baetens, Eva Swinnen, Chris Baeken, Frank Van Overwalle, Natacha Deroost · 2024 · Journal of Neuroscience Research
  46. Rat Pharmacokinetics and In Vitro Metabolite Identification of KM-819, a Parkinson’s Disease Candidate, Using LC-MS/MS and LC-HRMS
    Hae-In Choi, Tae‐Heon Kim, Jin Woo Kim, Gi Ju Lee, Jinyoung Choi, Yoon‐Jee Chae, Eunhee Kim, Tae‐Sung Koo · 2024 · Molecules
  47. Early B Cell Factor 3 (EBF3) attenuates Parkinson's disease through directly regulating contactin-associated protein-like 4 (CNTNAP4) transcription: An experimental study
    Wentao Hu, Menghan Wang, Guifang Sun, Limin Zhang, Hong Lu · 2024 · Cellular Signalling
  48. Hippocampus and olfactory impairment in Parkinson disease: a comparative exploratory combined volumetric/functional MRI study
    Michele Porcu, Luigi Cocco, Francesco Marrosu, Riccardo Cau, Josep Puig, Jasjit S. Suri, Luca Saba · 2024 · Neuroradiology
  49. Dietary Natural Flavonoids: Intervention for MAO ‐B Against Parkinson's Disease
    Ashini Singh, Suman Sinha, Niraj Kumar Singh · 2024 · Chemical Biology & Drug Design
  50. A Hybrid CNN-BiLSTM Neural Network Architecture for Early Prediction of Parkinson's Disease
    Mrityunjay Kumar Chauhan, Prasun Ghosal · 2024 · IEEE International Symposium on Smart Electronic Systems (iSES)
  51. Observation and Execution
    Christoph Borst, Franziska Zacharias, Florian Schmidt, Daniel Sebastian Leidner, Máximo A. Roa, Katharina Hertkorn, Gerhard Grunwald, Pietro Falco, Ciro Natale, Emilio Maggio · 2012 · Springer tracts in advanced robotics
  52. Impact of Footwear and Foot Deformities in patients with Parkinson's disease: A Case-Series Study
    Eloy Trillo Novo, Daniel López‐López, Carmen de Labra, Marta Elena Losa‐Iglesias, Ricardo Vallejo, César Calvo‐Lobo, Carlos Romero Morales, Marta San‐Antolín · 2020 · International Journal of Medical Sciences
  53. Implicit learning of perceptual sequences is preserved in Parkinson’s disease.
    Mahyar Firouzi, Kris Baetens, Eva Swinnen, Catalina Duta, Chris Baeken, Frank Van Overwalle, Natacha Deroost · 2021 · Neuropsychology
  54. Clinical factors and dopamine transporter availability for the prediction of outcomes after globus pallidus deep brain stimulation in Parkinson’s disease
    Seung Hyun Lee, Mi‐Na Kim, Jooyoung Lee, Jae Woo Kim, Mi Sun Kim, Sungyang Jo, Sang Ryong Jeon, Sun Ju Chung · 2022 · Scientific Reports
  55. Characterization of the Basic Membrane Properties of Neurons of the Rat Dorsal Motor Nucleus of the Vagus in Paraquat-Induced Models of Parkinsonism
    Cecilia Bove, F. Holly Coleman, Renato Alberto Travagli · 2019 · Neuroscience
  56. Opicapone enhances the reversal of MPTP-induced Parkinson-like syndrome by levodopa in cynomolgus monkeys
    Maria João Bonifácio, Filipa Sousa, Patrı́cio Soares-da-Silva · 2020 · European Journal of Pharmacology
  57. Uric acid: The role in the pathophysiology and the prediction in the diagnosis of Parkinson’s disease : A Turkish-based study
    Buse Çağla Arı, Esma Kobak Tur, Füsun Mayda Domaç, Gülay Kenangıl · 2022 · Ideggyógyászati Szemle
  58. Cortical microstructural alterations in different stages of Parkinson’s disease
    Xueqin Bai, Tao Guo, Xiaojun Guan, Cheng Yu Zhou, Jingjing Wu, Haoting Wu, Xiaocao Liu, Chengqing Wu, Jingwen Chen, Jiaqi Wen et al. · 2024 · Brain Imaging and Behavior
  59. Bradykinesia and postural instability in a model of prodromal synucleinopathy with α-synuclein aggregation initiated in the gigantocellular nuclei
    Vasileios Theologidis, Sara Almeida Ferreira, Nanna Møller Jensen, Diana Gomes Moreira, Ole Andreas Ahlgreen, Mads W. Hansen, Emilie D. Rosenberg, Mette Richner, Islam Mustafa Galal Faress, Hjalte Gram et al. · 2025 · Acta Neuropathologica Communications
  60. Catecholamine Dysregulation in Former American Football Players
    Suzan van Amerongen, Elaine R. Peskind, Yorghos Tripodis, Charles H. Adler, Laura Joan Balcer, Charles B. Bernick, Michael Louis Alosco, Douglas I. Katz, Sarah Jane Banks, William Barr et al. · 2025 · Neurology
  61. Application of EEG microstates in Parkinson's disease
    Zhen Li, Xiaodong Zhu · 2025 · Parkinsonism & Related Disorders
  62. Caloric Restriction Mimetics as Priming Agents of Mesenchymal Stem Cells Secretome to Enhance Regenerative Responses to Parkinson’s Disease
    Bárbara Carneiro-Pereira, Filipa Ferreira-Antunes, Jonas Campos, António José Salgado, Belém Sampaio‐Marques · 2025 · Molecules
  63. An Evaluation of VR Games and Haptic Feedback for Upper Limb Rehabilitation for Individuals with Parkinson’s Disease
    Meldin Bektic, Brittany M. Smith, Angela L. Ridgel, Kwangtaek Kim · 2025 · Machines
  64. Trained immunity in acute and chronic neurological diseases
    Sijia Zhang, Arthur Liesz · 2026 · eLife
  65. Modeling Cues May Reduce Sway Following Sit-To-Stand Transfer for People with Parkinson’s Disease
    Rebecca A. Martin, George D. Fulk, Leland E. Dibble, Ali Boolani, Edgar Ramos Vieira, Jennifer Canbek · 2023 · Sensors
  66. Effects of SPEAK OUT! & LOUD Crowd on Functional Speech Measures in Parkinson's Disease
    Lauren Sullivan, Elizabeth Martin, Kristen M. Allison · 2024 · American Journal of Speech-Language Pathology
  67. miR-193b-3p/ PGC-1α pathway regulates an insulin dependent anti-inflammatory response in Parkinson's disease
    Lucia Mesarosova, Mirte Scheper, Anand M. Iyer, Jasper J. Anink, James Dominic Mills, Eleonora Aronica · 2024 · Neurobiology of Disease
  68. Structural and Functional Characterization of the Most Frequent Pathogenic PRKN Substitution p.R275W
    Bernardo A. Bustillos, Liam T. Cocker, Matt Coban, Caleb A. Weber, Jenny M. Bredenberg, Paige K Boneski, Joanna S. Siuda, Jarosław W. Sławek, Andreas Puschmann, Derek P. Narendra et al. · 2024 · Cells
  69. Forged Channel: A Breakthrough Approach for Accurate Parkinson's Disease Classification using Leave-One-Subject-Out Cross-Validation
    A. Hamidi, Kamal Mohamedpour, M. Yousefi · 2024
  70. Influence of the Gut Microbiota, Metabolism and Environment on Neuropsychiatric Disorders
    Mengxia Wang, Yan Ma, Bao Zeng, Wenhao Yang, Cuihong Huang, Ben-Qin Tang · 2024 · Current Clinical Pharmacology
  71. Overlap in the diagnostic criteria of frontotemporal dementia syndromes with parkinsonism
    Sami V. Heikkinen, Kasper Katisko, Annakaisa Haapasalo, Anne M. Portaankorva, Päivi H. Hartikainen, Eino Solje · 2025 · Journal of Alzheimer s Disease
  72. Slightly viscous oxidized alginate dispersions as vehicles for intranasal administration of the α-synuclein aggregation inhibitor Anle 138b in free form or encapsulated in solid lipid nanoparticles
    Rosanna Mallamaci, Stefano Castellani, Limosani Francesca, P. G. Medaglia, Giuseppe Fracchiolla, Rosa Angela Cardone, Lorenzo Guerra, Francesca Tripaldi, Vito Porcelli, Antonella Muscella et al. · 2025 · International Journal of Pharmaceutics
  73. An integrated bioinformatics and machine learning approach to identifying biomarkers connecting parkinson’s disease with purine metabolism-related genes
    Yao Wang, Dong Wu, Man Zheng, Tiantian Yang · 2025 · BMC Neurology
  74. From chronic stress and anxiety to neurodegeneration: Focus on neuromodulation of the axon initial segment
    Jelena Radulovic, Sanja Ivković, Miroslav Adžić · 2022 · Handbook of clinical neurology
  75. Enfermedad de Parkinson
    Karla Paola Chaves Morales, Daniela Sofía Padilla Elizondo, Ricardo Vargas Fernández · 2022 · Revista Medica Sinergia
  76. The protective role of cigarette smoking against Parkinson’s disease via moderation of the interaction between iron deposition in the nigrostriatal pathway and clinical symptoms
    Quanquan Gu, Xiaocao Liu, Qingze Zeng, Xiaojun Guan, Cheng Zhou, Tao Guo, Baorong Zhang, Minming Zhang · 2022 · Quantitative Imaging in Medicine and Surgery
  77. A meta-analysis of the effect of multidisciplinary comprehensive care on health-related quality of life and Unified Parkinson’s Disease Rating Scale in Parkinson’s disease
    Ting Li, Xiumei Zou, Yujuan Kang, Mingzhu Sun, Xi Huang, Xianyan Duan · 2023 · Advances in Clinical and Experimental Medicine
  78. How to prevent cognitive overload in the walking-arithmetic dual task among patients with Parkinson’s disease
    Ying Xu, Canru Geng, Tong Tang, Juanying Huang, Ying Hou · 2023 · BMC Neurology
  79. The dual role of striatal interneurons: circuit modulation and trophic support for the basal ganglia
    Elliot Wegman, Marlena Wosiski‐Kuhn, Yu Luo · 2023 · Neural Regeneration Research
  80. Parkinsonism as a late presentation of lymphomatosis cerebri following high-dose chemotherapy with autologous stem cell transplantation for primary central nervous system lymphoma
    Sarah A. Merrill, David J. Mauler, Kent R. Richter, Aditya Raghunathan, Jose Francisco Leis, Maciej M. Mrugała · 2020 · Journal of Neurology
  81. Fixed-dose combination therapy for Parkinson’s disease with a spotlight on entacapone in the past 20 years: a reduced pill burden and a simplified dosing regime
    András Salamon, Dénes Zádori, László Szpisjak, Péter Klivènyi, László Vécsei · 2020 · Expert Opinion on Pharmacotherapy
  82. The link between sleep duration and stroke risk
    Yu Cheng, Yuchuan Ding, Ahmed Elmadhoun, Xunming Ji, Yu Cheng · 2025 · Brain Circulation
  83. Neurofilament Light Chain from Neuronally Derived Extracellular Vesicles in Differentiating Parkinson’s Disease from Essential Tremor with Resting Tremor
    Selena Mimmi, Costanza Maria Cristiani, Mariagrazia Talarico, Anna Maria Tolomeo, Elvira Immacolata Parrotta, Luana Scaramuzzino, Valentina Crapella, Elisabetta Pingitore, Enrico Iaccino, Giovanni Cuda et al. · 2025 · Molecular Neurobiology
  84. Association of dopamine depletion and cholinergic basal forebrain atrophy with brain metabolism and cognition in Parkinson's disease
    Jung Hyun Lee, Mina Park, Sung Jun Ahn, Jae‐Hoon Lee, Young Hoon Ryu, Han Soo Yoo, Chul Hyoung Lyoo · 2025 · Journal of Parkinson s Disease
  85. Bradykinesia and rigidity modulated by functional connectivity between the primary motor cortex and globus pallidus in Parkinson’s disease
    Kaoru Kinugawa, Tomoo Mano, Shigekazu Fujimura, Tsunenori Takatani, Toshiteru Miyasaka, Kazuma Sugie · 2023 · Journal of Neural Transmission
  86. Machine‐learning model for the prediction of acute orthostatic hypotension after levodopa administration
    Zhu Liu, Shinuan Lin, Junhong Zhou, Xuemei Wang, Zhan Wang, Yaqin Yang, Huizi Ma, Zhonglue Chen, Kang Ren, Lingyu Wu et al. · 2024 · CNS Neuroscience & Therapeutics
  87. Mitochondrial DNA heteroplasmy rises in substantial nigra of aged PINK1 KO mice
    Jie Li, Chunyan Xue, Qingtao Gao, Jieqiong Tan, Zhengqing Wan · 2019 · Biochemical and Biophysical Research Communications
  88. Functional training versus Mat Pilates in motor and non-motor symptoms of individuals with Parkinson's disease: study protocol for a randomized controlled trial
    Jéssica Moratelli, Kettlyn Hames Alexandre, Leonessa Boing, Melissa de Carvalho Souza Vieira, Adriana Coutinho de Azevedo Guimarães · 2022 · Motriz Revista de Educação Física
  89. Correlation of SV2C rs1423099 single nucleotide polymorphism with sporadic Parkinson's disease in Han population in Southern China
    Zixin Tan, Yuwan Lin, Miaomiao Zhou, Wenyuan Guo, Jiewen Qiu, Liuyan Ding, Zhuohua Wu, Pingyi Xu, Xiang Chen · 2023 · Neuroscience Letters
  90. Parkinson’s Neuropathology Puzzle: A Systematic Review Uncovering the Pathological Culprits Behind the Neurological Disease
    Abdelrahman Abaza, Aneeque Jamil, Sai Dheeraj Gutlapalli, Marya Ali, Mrinal J P Oble, Shamsun Nahar Sonia, Sherie George, Srushti R Shahi, Zahra Ali, Safeera Khan · 2023 · Cureus
  91. New fraternine analogues: Evaluation of the antiparkinsonian effect in the model of Parkinson's disease
    Andréia Biolchi Mayer, Henrique de Oliveira Amaral, Danilo Gustavo Rodrigues de Oliveira, Gabriel Avohay Alves Campos, Priscilla Galante Ribeiro, Solange Rego, Adolfo Carlos Barros de Souza, Raffael Júnio Araújo de Castro, Anamélia Lorenzetti Bocca, Márcia Renata Mortari · 2023 · Neuropeptides
  92. A Preliminary Study of Voluntary Cough Motor Performance and Learning With Skill Training and Biofeedback
    James C. Borders, Emilie R. Lowell, Jessica E. Huber, Lori Quinn, Michelle S. Troche · 2024 · Journal of Speech Language and Hearing Research
  93. Pharmacological Assessment of Aqueous Ethanolic Extract of Thalictrum Foetidum Against Haloperidol-Induced Parkinson’s Like Symptoms in Animal Model: A Dose-Dependent Study With Mechanistic Approach
    Han Jiang-yu, Xu Hao, Mishal Fatima, Zunera Chauhdary, Ayesha Jamshed, Hafiz Muhammad Abdur Rahman, Rida Siddique, Muhammad Asif, Saba Rana, Liaqat Hussain · 2024 · Dose-Response
  94. Oxidative stress signaling and regulated cell death in Parkinson's disease
    Carlos Velez‐Pardo, Marlene Jiménez-Del-Río · 2020 · Elsevier eBooks
  95. Comparison of the mass and amount of intramuscular non-contractile tissue of the trunk and lower extremity muscles between patients with Parkinson’s disease and community-dwelling older adults
    Mitsuhiro Masaki, Maki Kasahara, Moeka Takeuchi, Kota Minakawa, Yukika Inagaki, Yukine Ogawa, Yoshino Sato, Minori Yokota, Seina Maruyama, Ryoko Usuki et al. · 2022 · Neurological Sciences
  96. The implications of the foot health status in Parkinson patients: A case–control study
    Ana María Jiménez‐Cebrián, Luis López‐López, Marta Elena Losa‐Iglesias, Ricardo Vallejo, Carlos Romero Morales, Daniel López‐López, Alonso Montiel‐Luque, Emmanuel Navarro‐Flores, Carmen de Labra · 2022 · International Wound Journal
  97. The predictive relationships between advanced dynamic balance and physical activity/quality of life in Parkinson's disease
    Sz-Yan Wu, Tsu‐Kung Lin, Chien‐Yu Pan, Chia‐Liang Tsai · 2023 · Human Movement Science
  98. Reversible Pharmacological Induction of Motor Symptoms in MPTP-Treated Mice at the Presymptomatic Stage of Parkinsonism: Potential Use for Early Diagnosis of Parkinson’s Disease
    Gulnara Rinatovna Khakimova, Elena A. Kozina, V. G. Kucheryanu, Michael V. Ugrumov · 2016 · Molecular Neurobiology
  99. Mapping knowledge domain of acupuncture for Parkinson’s disease: a bibliometric and visual analysis
    Yanqing Zhao, Li Kai Huang, Wentao Li · 2024 · Frontiers in Aging Neuroscience
  100. Relationship between autonomic dysfunction and sexual dysfunctions in Parkinson’s patients
    Hatice Varlıbaş, Hacı Ali Erdoğan, İbrahim Acır, Vıldan Yayla · 2025 · Frontiers in Aging Neuroscience